News 2020-07-03
The Launching of Official Website for 2020 Pharmaceutical Crystallization Summit
J-Star Research, a wholly owned subsidiary of Porton Pharma Solution Ltd., engages with Xtalpi and a broad selection of industrial and academic leaders to host the 2020 Pharmaceutical Crystallization Summit on October 7th and 8th, 2020 (Live).
We will take a close look at the ever-expanding toolbox of capabilities needed to meet challenges in API crystallization. The Summit will emphasize the importance of understanding fundamentals and root causes of problems to effectively speed up process and product development.
Considering the impact of the Covid-19 outbreak, this year’s Summit will be held online (live). This provides the advantage of allowing more attendees than a normal face-to-face meeting. The registration for invited attendees starts in June, and the registration for the general public starts on August 7th, 2020. Registration Reminder for public audience will be released through Porton official channels in August.
Warmly welcome our customers and investors to follow us on this Summit in the coming months.
Website:
https://crystallization-summit.jstar-research.com/
LinkedIn:
https://www.linkedin.com/company/center-for-pharma-crystallization-cfpc/
Others
More
News 2026-08-05
Porton Advanced Secures Drug Manufacturing License (Class C), Expanding CDMO Services to Commercialization
Porton Advanced Solutions Ltd. has officially been granted a Drug Manufacturing License (Class C) by the National Medical Products Administration (NMPA). This milestone qualifies Porton Advanced to undertake commercial contract manufacturing for Cell and Gene Therapy (CGT) products, extending its CDMO services from process development and clinical production through to the commercialization stage.

News 2026-07-08
Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
Porton Advanced’s UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance